Navigation Links
AstraZeneca and Abbott End License Agreement for the Development of CERTRIAD
Date:12/22/2010

WILMINGTON, Del., Dec. 22, 2010 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that it has notified Abbott that it will discontinue the development of CERTRIAD™ (rosuvastatin calcium and fenofibric acid), which was being investigated for the treatment of mixed dyslipidemia. This means the co-development and license agreement with Abbott will end on January 22, 2011.  

A Complete Response Letter (CRL) for the CERTRIAD New Drug Application (NDA) was received from the U.S. Food and Drug Administration (FDA) on March 30, 2010.

The companies reached this decision after careful review and consideration of the CRL and the resulting regulatory delay, and have determined that the development of CERTRIAD is no longer commercially attractive.  

AstraZeneca will continue to focus on other development priorities both within and outside of the cardiovascular disease therapeutic area.

NOTES TO EDITORS:

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines.  As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009.  In the United States, AstraZeneca is a $14.8 billion healthcare business.   

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).


'/>"/>
SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
8. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
9. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
10. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
11. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Columbia Laboratories, Inc. ... a provider of pharmaceutical development, clinical trial manufacturing, and ... today announced that it will participate at the upcoming ... Conference, to be held in New York ... at 11:15am on September 9, 2014 at the New ...
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... development of drugs targeting unmet needs in oncology, autoimmune and ... 2014 Health Care Conference to be held at The New ... on September 3-4, 2014. Alan Fuhrman ... and its lead drug candidate, quizartinib, at 1:10 p.m. ET ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... 23, 2011 Arctic Ease is proud to announce that ... Team Arctic Ease®.  Davis will serve as a face of ... introduce Arctic Ease® to millions of sports fans across the ... of cold therapy that are odorless, menthol free and do ...
... (Nasdaq: ROCM ) announced today that Roger W. ... conclusion of the Company,s 2012 Annual Meeting of Shareholders to ... of his current term. Board Chairman and CEO ... our Board since 1995.  His cheerful intelligence and gracious temperament ...
Cached Medicine Technology:Vernon Davis Joins Team Arctic Ease® as Spokesperson for Arctic Ease® Cryotherapy Wraps and Pads 2Vernon Davis Joins Team Arctic Ease® as Spokesperson for Arctic Ease® Cryotherapy Wraps and Pads 3Rochester Medical Director Schnobrich to Retire 2
(Date:8/27/2014)... 2014 Dr. Stewart Shofner ... multitudes of patients suffering from impaired vision. Some of ... vision correction surgery . Recently, Dr. Shofner has noticed ... an eye exam and also online. To help patients ... myths about glaucoma. , 1)    Myth: People with perfect vision ...
(Date:8/27/2014)... York (PRWEB) August 27, 2014 The ... ( http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline for plaintiffs ... an August 2014 Order issued by U.S. District Judge ... wishing to enroll in the DePuy ASR Settlement Program ... DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The ... and nurses by healthcare research group Black Book ... are not adequately staffed, supplied or built to ... “Black Book initiated this annual survey to gain ... hospital infection control, epidemiology and emergency preparedness systems,” ...
(Date:8/27/2014)... Ticket Down is a dependable source for authentic ... Miami. The Brazilian national soccer team will tangle with ... Life Stadium in Miami Gardens, Florida. The two South ... Cup earlier this year when Brazil got the 2-1 win, ... Federation announced earlier this week that Neymar would return from ...
(Date:8/27/2014)... -- There,s been controversy for years over whether the ... might raise the odds of mental health issues in ... 13,000 children finds no rise in the risk of ... while pregnant, but some data suggesting a heightened risk ... findings challenge prior research pointing to a link between ...
Breaking Medicine News(10 mins):Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 2Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 3
... KINGSTON, Ont. –Terminally-ill patients in Canada are not ... concerning resuscitation after a heart attack //or other ... Medicine Daren Heyland. A national study has found ... prepared regarding the different options available to turn ...
... Australia’s suicide rate has been steadily declining since its ... in the latest issue of the Medical Journal of ... The Adelaide Clinic, warned the improvement is no reason ... rates does not negate its tragedy for the individuals ...
... London – Intelligence quotient seems to hold sway on the ... high spirits, a new research has found. //Scottish researchers delved ... feeling and IQ, discovering that the clever lot benefit by ... lesser IQ. ,The discomfort associated with a ...
... Qadeer Khan, who underwent prostate surgery, was discharged from ... ,Khan, 70, was driven out from a rear exit ... of the Aga Khan Hospital where his cancerous prostate ... ,Information Minister Mohammad Ali Durrani had indicated after visiting ...
... discovered a key enzyme that appears to play a vital ... in rats. This is the first genetic link to blood ... for it. The study is published in the September issue ... a protein that is abundant in muscle and is necessary ...
... said that severely ill malaria patients would benefit a ... fluids.// Researchers from the Imperial College in London and ... to replace fluids for children ill with malaria. ... of the children who received the new treatment died, ...
Cached Medicine News:Health News:Critically Ill patients ill-equipped to handle end-of life matters 2Health News:Suicide Rates Declining 2Health News:Genetic Link To High Blood Pressure 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: